Cellyan Biotechnology Ownership | Who Owns Cellyan Biotechnology?


OverviewChart

Cellyan Biotechnology Ownership Summary


Cellyan Biotechnology is owned by 0.60% institutional investors, 62.26% insiders, and 37.14% retail investors. Two sigma investments, lp is the largest institutional shareholder, holding 0% of HKPD shares.

HKPD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCellyan Biotechnology0.60%62.26%37.14%
SectorHealthcare Stocks 35.56%12.08%52.36%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Two sigma investments, lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma investments, lp---

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp---10.83K

Top Sellers

HolderShares% AssetsChange
Two sigma investments, lp---10.83K

Sold Out

HolderChange
Two sigma investments, lp-10.83K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20264-62,356-15.27%-119.17%--100.00%3-
Dec 31, 20254100.00%73,590507.33%-5186.42%3200.00%--100.00%
Sep 30, 20252-66.67%12,117-83.53%-23.17%1-75.00%1-50.00%
Jun 30, 2025650.00%73,56142.34%-285.08%4-2-
Mar 31, 20254-51,681---4---

HKPD Ownership FAQ


Does Blackrock own Cellyan Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Cellyan Biotechnology.

Who is Cellyan Biotechnology’s biggest shareholder by percentage of total assets invested?

Two sigma investments, lp is Cellyan Biotechnology’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Cellyan Biotechnology shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools